This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Experts
Deborah Bookwalter
Principal Research Associate
Contact
DeborahBookwalter@westat.comOverview
Deborah Bookwalter, ScD, is a senior epidemiologist with 20+ years of experience in chronic disease epidemiologic research. She is the Principal Investigator for the Data Coordinating Center for the Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P), NHLBI’s flagship program for improving blood safety and availability and for advancing transfusion medicine practice. She also serves as a senior epidemiologist and technical advisor supporting NIEHS Epidemiology Branch research.
Prior to joining Westat in 2018, much of her previous experience had been in the design and analysis of large long-term prospective cohort studies, with a research focus on cancer, obesity, and diabetes.
Education
- ScD, Epidemiology, Harvard School of Public Health
- MS, Epidemiology, Harvard School of Public Health
- BA, Molecular and Cell Biology, University of California, Berkeley
-
Associations between ABO non-identical platelet transfusions and patient outcomes-A multicenter retrospective analysis
Transfusion
January 2023
D.W. Bougie, S.E. Reese, R.J. Birch, Deborah Bookwalter, P.K.1713457 Mitchell, D. Roh, L.B. Kreuziger, et al.
DOILink for: Associations between ABO non-identical platelet transfusions and patient outcomes-A multicenter retrospective analysis -
Air pollution and breast cancer: An examination of modification by underlying familial breast cancer risk
31,
Cancer Epidemiology, Biomarkers and Prevention
January 2022
N.M. Niehoff, M.B. Terry, Deborah Bookwalter, J.D. Kaufman, K.M. O'Brien, D.P. Sandler, A.J. White
DOILink for: Air pollution and breast cancer: An examination of modification by underlying familial breast cancer risk -
Waning of vaccine effectiveness against moderate and severe COVID-19 among adults in the US from the VISION network: Test negative, case-control study
379,
BMJ
January 2022
J.M. Ferdinands, S. Rao, B.E. Dixon, P.K. Mitchell, M.B. DeSilva, S.A. Irving, N. Lewis, et al.
DOILink for: Waning of vaccine effectiveness against moderate and severe COVID-19 among adults in the US from the VISION network: Test negative, case-control study